Paul H. Sugarbaker
保罗·苏加贝克
MD, FACS, FRCS
Director, Program in Peritoneal Surface Oncology腹膜表面肿瘤学项目主任
👥Biography 个人简介
Paul H. Sugarbaker is the pioneering father of peritoneal surface oncology and HIPEC. Over five decades at MedStar Washington Hospital Center, he developed and standardized cytoreductive surgery (CRS) combined with HIPEC, transforming peritoneal metastases from universally fatal to potentially curable. He established the peritoneal cancer index (PCI) and completeness-of-cytoreduction score used worldwide.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Cytoreductive Surgery and HIPEC Standardization
Developed and globally disseminated the combined CRS + HIPEC approach for peritoneal surface malignancies, including detailed surgical techniques, patient selection criteria, and the peritoneal cancer index (PCI) scoring system adopted worldwide.
Pseudomyxoma Peritonei Treatment
Established CRS + HIPEC as the curative-intent standard for pseudomyxoma peritonei and appendiceal mucinous neoplasms, reporting long-term survival outcomes at his Washington center over thousands of cases.
Peritoneal Mesothelioma Outcomes
Demonstrated that aggressive CRS + HIPEC in selected patients with malignant peritoneal mesothelioma achieves median survival exceeding 5 years, establishing surgical treatment as superior to systemic therapy alone.
Representative Works 代表性著作
Peritoneal Carcinomatosis: Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
Seminars in Surgical Oncology (1996)
Landmark paper establishing the rationale and technique for CRS + HIPEC, becoming foundational reading for peritoneal oncology.
Long-term survival with cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis
Annals of Surgery (2001)
Reported long-term survival data for CRS + HIPEC across multiple peritoneal malignancies, cementing the role of aggressive locoregional treatment.
Pseudomyxoma peritonei syndrome
Diseases of the Colon & Rectum (2002)
Comprehensive analysis of CRS + HIPEC outcomes in pseudomyxoma peritonei, establishing current treatment standards.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 保罗·苏加贝克 的研究动态
Follow Paul H. Sugarbaker's research updates
留下邮箱，当我们发布与 Paul H. Sugarbaker（MedStar Washington Hospital Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment